Is a complete CSE/DOSE research report available?

No complete published report is available for cse/DOSE (CSE/DOSE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

CSE/DOSE (CSE/DOSE)

Canadian Securities Exchange: CSE/DOSE · CAD

CA$0.12

+0.01 (+9.1%)· Recorded snapshot

Market cap	16.4M
Revenue (ttm)	2.6M
Net income (ttm)	-3.2M
EPS (ttm)	-CA$0.02
Shares out	136.4M
Volume	34,500
Beta	-0.84

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6M
Net income (ttm): -3.2M
EPS (ttm): -CA$0.02
Market cap: 16.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-07 02:00 UTC

All CSE/DOSE indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

CAD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 22.2M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA75339A1012
Last refreshed	2026-09-07
Market cap	CAD 16.4M
Price	CAD 0.12
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/DOSE
Website	https://rapid-dose.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.36%
EV/FCF	105.2x
EV/Sales	8.61x
FCF yield	1.29%
P/B ratio	-2.17x
P/S ratio	6.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-73.59%
EBITDA Margin	-70.78%
FCF margin	8.18%
Gross margin	49.83%
Gross Profit	CAD 1.3M
Gross Profit Growth	-2.42%
Gross Profit Growth Q	-20.39%
Gross Profit Growth3 Y	42.55%
Gross Profit Growth5 Y	-2.09%
Net Income	CAD -3.2M
Net Income Growth Quarters	6%
Net Income Growth Years	1%
Pretax Margin	-123.09%
Profit Margin	-123.09%
ROA	-33.3
Roa5y	-91.6
ROCE	33.87

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-35.15%
Cagr3y	-5.01%
Cagr5y	-27.28%
EPS Growth Quarters	6
EPS Growth Years	1
FCF Growth Qo Q	-92.64%
OCF Growth Qo Q	-92.64%
Revenue Growth	4.3x
Revenue Growth Q	-25.32x
Revenue Growth Qo Q	-11.51x
Revenue Growth Years	3x
Revenue Growth3 Y	42.11x
Revenue Growth5 Y	10.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.72
Assets	CAD 3.1M
Cash	CAD 14,653
Current Assets	CAD 324,442
Current Liabilities	CAD 8.7M
Debt	CAD 5.8M
Debt FCF	CAD 27.56
Equity	CAD -7.5M
Interest Coverage	-1.49
Liabilities	CAD 10.7M
Long Term Assets	CAD 2.8M
Long Term Liabilities	CAD 1.9M
Net Cash	CAD -5.8M
Net Cash By Market Cap	CAD -35.37
Net Debt FCF	CAD 27.49
Tangible Book Value	CAD -7.5M
Tangible Book Value Per Share	CAD -0.06
WACC	4.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.04
Inventory Turnover	6.09
Net Working Capital	CAD -4.5M
Quick ratio	0.02
Working Capital	CAD -8.4M
Working Capital Turnover	CAD -0.35

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-5.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-35.14%
200-day SMA	0.13
3Y total return	-14.29%
50-day SMA	0.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-79.66%
All Time High	1.33
All Time High Change	-90.98%
All Time High Date	2019-01-04
All Time Low	0.07
All Time Low Change	71.43%
All Time Low Date	2022-08-25
ATR	0.01
Beta	-0.84
Beta1y	1.04
Beta2y	0.51
Ch YTD	-7.69
High	0.12
High52	0.19
High52 Date	2025-11-21
High52ch	-36.84%
Low	0.1
Low52	0.08
Low52 Date	2026-08-04
Low52ch	50%
Ma50ch	17.88%
Price vs 200-day SMA	-5.96%
RSI	57.55
RSI Monthly	42.76
RSI Weekly	50.31
Sharpe ratio	0.01x
Sharpe Ratio3y	0.49x
Sharpe Ratio5y	0.46x
Sortino ratio	0.06
Sortino Ratio3y	0.81
Sortino Ratio5y	0.78
Total Return	-5.68%
Tr YTD	-7.69
Tr1m	26.32%
Tr3m	20%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	115,714,023%
Net Borrowing	109,115
Shares Insiders	15.19%
Shares Out	136,444,838
Shares Qo Q	-0.32%
Shares Yo Y	5.68%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -22,750
Adjusted OCF	-22,750
Average Volume	47,248.6x
Bv Per Share	-0.06
CAPEX	CAD 0
Ch1m	26.32
Ch1y	-35.14
Ch3m	20
Ch3y	-14.29
Ch5y	-79.66
Ch6m	-17.24
Change	9.09%
Change From Open	14.29
Close	0.11
Days Gap	-4.55
Depreciation Amortization	72,357
Dollar Volume	4,140
Earnings Date	2026-10-30
EBIT	CAD -1.9M
EBITDA	CAD -1.8M
EPS	CAD -0.02
F Score	2
FCF	CAD 210,688
FCF EV Yield	0.95x
FCF Per Share	CAD 0
Financing CF	-268,532
Fiscal Year End	February
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2026-05-31
Ma150	0.12
Ma150ch	3.81%
Ma20	0.1
Ma20ch	16.5%
Net CF	-57,844
Next Earnings Date	2026-10-30
Open	0.11
P FCF Ratio	77.71
P OCF Ratio	77.71
Position In Range	100
Ppne	2,733,280
Price Date	2026-09-04
Relative Volume	0.75x
Revenue	2,575,091x
SBC By Revenue	9.07x
Share Based Comp	233,438
Tr6m	-17.24%
Volume	34,500
Z Score	-24.98

CSE/DOSE (CSE/DOSE)

Price

Financial snapshot

Fair-value bridge

Latest news · CSE/DOSE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CSE/DOSE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on CSE/DOSE

Frequently asked questions